Assessment of Drug-drug Interactions Between Feminizing Hormone Therapy and Emtricitabine/Tenofovir Alafenamide Concomitantly for Pre-exposure Prophylaxis Among Transgender Women
Clinical trial NCT04590417 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04590417
- Sponsor
- Thai Red Cross AIDS Research Centre
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-24
- Primary completion
- 2024-01-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.